Development of a Small D-Enantiomeric Alzheimer’s Amyloid-β Binding Peptide Ligand for Future In Vivo Imaging Applications
Alzheimer’s disease (AD) is a devastating disease affecting predominantly the aging population. One of the characteristic pathological hallmarks of AD are neuritic plaques, consisting of amyloid-β peptide (Aβ). While there has been some advancement in diagnostic classification of AD patients accordi...
Main Authors: | Funke, Susanne Aileen, Bartnik, Dirk, Glück, Julian Marius, Piorkowska, Kasia, Wiesehan, Katja, Weber, Urs, Gulyas, Balazs, Halldin, Christer, Pfeifer, Andrea, Spenger, Christian, Muhs, Andreas, Willbold, Dieter |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404088/ |
Similar Items
-
Peptides for Therapy and Diagnosis of Alzheimer’s Disease
by: Funke, Susanne Aileen, et al.
Published: (2012) -
Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease
by: Dammers, Christina, et al.
Published: (2016) -
The D-amino acid peptide D3 reduces amyloid fibril boosted HIV-1 infectivity
by: Widera, Marek, et al.
Published: (2014) -
Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study
by: Rodriguez-Vieitez, Elena, et al.
Published: (2015) -
Detection of Soluble Amyloid-β Oligomers and Insoluble High-Molecular-Weight Particles in CSF: Development of Methods with Potential for Diagnosis and Therapy Monitoring of Alzheimer's Disease
by: Funke, Susanne Aileen
Published: (2011)